{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:42Z","timestamp":1793293842558,"version":"4.5.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is prevalent in East Asia. However, the use of glucocorticoids (GCs) in the treatment of SFTS remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective cohort study, we collected the data from patients with SFTS at Wuhan Union Hospital to evaluate the effect of GC therapy. Mortality and secondary infections were compared as outcomes. After searching public databases, we also included articles that examined GC use in patients with SFTS for meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients treated with GC had higher fatality rates (21.1% vs. 11.9%, respectively; <jats:italic>P<\/jats:italic>=0.006) and a longer length of stay (10.6 \u00b1 5.1 vs. 9.5 \u00b1 4.2, respectively; <jats:italic>P<\/jats:italic>=0.033). In cohorts adjusted using propensity score matching and inverse probability of treatment weighting, no significant differences in fatality rates and length of stay were observed. A meta-analysis of 4243 SFTS patient revealed that those treated with GCs had significantly higher mortality (OR=3.46, 95% CI =2.12-5.64, <jats:italic>P<\/jats:italic>&amp;lt;0.00001) and secondary infection rate (OR=1.97, 95% CI=1.45-2.67, <jats:italic>P<\/jats:italic>&amp;lt;0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>GC should be used cautiously when treating SFTS. No significant differences were identified in terms of mortality and secondary infection rates between patients with SFTS treated with or without GC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1419015","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T06:07:23Z","timestamp":1722924443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The use of glucocorticoid in severe fever with thrombocytopenia syndrome: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yuzhang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3760\/cma.j.cn112338-20221009-00866","article-title":"[Epidemiological characteristics of tick-borne infectious diseases in Hubei Province, 2016-2021]","volume":"44","author":"Chen","year":"2023","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3760\/cma.j.cn112338-20220325-00228","article-title":"[Epidemiological characteristics of severe fever with thtrombocytopenia syndrome in China, 2011-2021]","volume":"43","author":"Chen","year":"2022","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s43440-021-00286-4","article-title":"Use of glucocorticoids and azithromycin in the therapy of COVID-19","volume":"73","author":"de Lemos Neto","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e111736","DOI":"10.1371\/journal.pone.0111736","article-title":"Age is a critical risk factor for severe fever with thrombocytopenia syndrome","volume":"9","author":"Ding","year":"2014","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3760\/cma.j.issn.1674-2397.2022.04.003","article-title":"Expert consensus on diagnosis and treatment of severe fever with thrombocytopenia syndrome","volume":"15","author":"Guang.","year":"2022","journal-title":"Chin. J. Clin. Infect. Diseases."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1002\/jmv.26877","article-title":"Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome","volume":"93","author":"He","year":"2021","journal-title":"J. Med. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009128","article-title":"Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study","volume":"15","author":"Jung","year":"2021","journal-title":"PloS Negl. Trop. Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165207","article-title":"Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013-2014","volume":"11","author":"Kato","year":"2016","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jiac.2016.01.022","article-title":"Severe fever with thrombocytopenia syndrome with myocardial dysfunction and encephalopathy: A case report","volume":"22","author":"Kawaguchi","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/v13050785","article-title":"Corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: A case-control study","volume":"13","author":"Kawaguchi","year":"2021","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3851\/IMP3036","article-title":"Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid","volume":"21","author":"Kim","year":"2016","journal-title":"Antivir Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s40064-016-2010-2","article-title":"Severe fever with thrombocytopenia syndrome presenting as hemophagocytic syndrome: two case reports","volume":"5","author":"Kitao","year":"2016","journal-title":"Springerplus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.595140","article-title":"SFTSV infection induced interleukin-1beta secretion through NLRP3 inflammasome activation","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1473-3099(14)70718-2","article-title":"Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis","volume":"14","author":"Liu","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B22","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"Nakamura","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17476348.2023.2177155","article-title":"Safety and efficacy of glucocorticoids in the treatment of COVID-19: A meta-analysis of randomized control trials","volume":"17","author":"Qiao","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/v13071213","article-title":"Clinical update of severe fever with thrombocytopenia syndrome","volume":"13","author":"Seo","year":"2021","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00150","article-title":"Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection","volume":"11","author":"Takayama-Ito","year":"2020","journal-title":"Front. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijid.2023.03.015","article-title":"Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study","volume":"130","author":"Wang","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ijid.2022.07.001","article-title":"Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study","volume":"122","author":"Xiong","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijid.2021.02.088","article-title":"Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study","volume":"105","author":"Xu","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/cir804","article-title":"Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome","volume":"54","author":"Zhang","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268822001108","article-title":"A ten-year assessment of the epidemiological features and fatal risk factors of hospitalised severe fever with thrombocytopenia syndrome in Eastern China","volume":"150","author":"Zu","year":"2022","journal-title":"Epidemiol. Infect."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1419015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T06:07:27Z","timestamp":1722924447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1419015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2024.1419015"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1419015","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"article-number":"1419015"}}